Alpha Cognition (ACOG) Research & Development (2023 - 2026)
Alpha Cognition (ACOG) posted quarterly Research & Development of $569749.0 for Q4 2025, down 45.24% year-over-year from $1.0 million in Q4 2024, and down 0.67% quarter-over-quarter from $573592.0 in Q3 2025.
Alpha Cognition (ACOG) Research & Development (2023 - 2026) Analysis & Trends
Alpha Cognition's Research & Development history runs 3 years deep, the most recent figure standing at $569749.0 for Q4 2025.
- In Q4 2025, Research & Development fell 45.24% year-over-year to $569749.0; the TTM figure through Dec 2025 stood at $1.9 million (down 52.35% YoY), while the FY2025 annual figure was $1.9 million, down 52.35% from the prior year.
- Research & Development for Q4 2025 stood at $569749.0, down from $573592.0 in the prior quarter.
- The five-year high for Research & Development was $1.4 million in Q3 2023, with the low at $317120.0 in Q2 2025.
- The 3-year median for Research & Development is $967200.0 (2024), against an average of $870401.7.
- The sharpest annual moves came in 2024 and 2025: Research & Development declined 6.27% in 2024, then sank 67.21% in 2025.
- Alpha Cognition's Research & Development stood at $1.1 million in 2023, then dropped by 6.27% to $1.0 million in 2024, then sank by 45.24% to $569749.0 in 2025.
- Business Quant data shows ACOG's Research & Development at $569749.0 in Q4 2025, $573592.0 in Q3 2025, and $317120.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 413.13 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 210.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 97.90 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -588.31 Mn |
| 10 | Alpha Cognition | 209.03 Mn | 167.59 Mn | 5.70 Mn | 2.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.01 Mn |
| Dec 31, 2025 | 569,749.00 |
| Sep 30, 2025 | 573,592.00 |
| Jun 30, 2025 | 317,120.00 |
| Mar 31, 2025 | 407,511.00 |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 996,029.00 |
| Jun 30, 2024 | 967,200.00 |
| Mar 31, 2024 | 916,716.00 |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | 1.25 Mn |